Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis

Journal of Clinical Investigation

Volumn 125, Issue 12, 2015, Pages 4699-4713

  Monin, Leticia ^a,b   Griffiths, Kristin L ^b   Lam, Wing Y ^c   Gopal, Radha ^a   Kang, Dongwan D ^d,e   Ahmed, Mushtaq ^b   Rajamanickam, Anuradha ^f   Cruz Lagunas, Alfredo ^g   Zúñiga, Joaquín ^g   Babu, Subash ^f   Kolls, Jay K ^h   Mitreva, Makedonka ^c,i,j   Rosa, Bruce A ⁱ   Ramos Payan, Rosalio ^k,l   Morrison, Thomas E ^m   Murray, Peter J ⁿ   Rangel Moreno, Javier ^k   Pearce, Edward J ^c   Khader, Shabaana A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Campus Box 8230 ^*  (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DOE JOINT GENOME INSTITUTE   (United States)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^f NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^g INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^h CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

ⁱ The Genome Institute   (United States)

^j Division of Infectious Diseases   (United States)

^k UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^l UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^m UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁿ ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; PRAZIQUANTEL; ARG1 PROTEIN, MOUSE; ARGINASE; ARGINASE I, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; GRANULOMA; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNIZATION; LUNG INJURY; LUNG TUBERCULOSIS; MACROPHAGE; MIXED INFECTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SPARGANOSIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TYPE 2 GRANULOMA; ANIMAL; BLOOD; ENZYMOLOGY; FEMALE; LUNG; MALE; METABOLISM; MICROBIOLOGY; PARASITOLOGY; PATHOLOGY; SCHISTOSOMIASIS MANSONI; TRANSGENIC MOUSE;

ANIMALS; ARGINASE; FEMALE; GRANULOMA; HUMANS; LUNG; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TUBERCULOSIS, PULMONARY;

EID: 84948799387     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77378     Document Type: Article

References (39)

1. Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health. 2013;34:271-286.
2. Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev. 2008;226:191-204.
3. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites-masters of regulation. Immunol Rev. 2004;201:89-116.
4. Diaz A, Allen JE. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol. 2007;37(12):3319-3326.
5. Rafi W, Ribeiro-Rodrigues R, Ellner JJ, Salgame P. 'Coinfection-helminthes and tuberculosis'. Curr Opin HIV AIDS. 2012;7(3):239-244.
6. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest. 2008;118(4):1311-1321.
7. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S. Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol. 2001;123(2):219-225.
8. Elias D, Akuffo H, Britton S. Helminthes could influence the outcome of vaccines against TB in the tropics. Parasite Immunol. 2006;28(10):507-513.
9. Elias D, Britton S, Aseffa A, Engers H, Akuffo H. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-β production. Vaccine. 2008;26(31):3897-3902.
10. Brown M, et al. Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am J Trop Med Hyg. 2006;74(5):819-825.
11. Elias D, Akuffo H, Thors C, Pawlowski A, Britton S. Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol. 2005;139(3):398-404.
12. Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, Britton S. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine. 2005;23(11):1326-1334.
13. + T helper cells mediate protective immunity against tuberculosis. J Clin Invest. 2013;123(2):712-726.
14. Gopal R, et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. Am J Respir Crit Care Med. 2013;188(9):1137-1146.
15. Pearce EJ, MacDonald AS. The immunobi-ology of schistosomiasis. Nat Rev Immunol. 2002;2(7):499-511.
16. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med. 1993;178(6):2243-2247.
17. Liu R, Dong HF, Guo Y, Zhao QP, Jiang MS. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schis-tosomiasis: a systematic review and meta-analy-sis. Parasit Vectors. 2011;4:201.
18. El Kasmi KC, et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol. 2008;9(12):1399-1406.
19. Pesce JT, et al. Arginase-1-expressing mac-rophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5(4):e1000371.
20. Barron L, et al. Role of arginase 1 from myeloid cells in th2-dominated lung inflammation. PLoS One. 2013;8(4):e61961.
21. Duque-Correa MA, et al. Macrophage argin-ase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas. Proc Natl Acad Sci USA. 2014;111(38):E4024-E4032.
22. Bowcutt R, et al. Arginase-1-expressing macro-phages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris. Parasite Immunol. 2011;33(7):411-420.
23. Kang DD, Lin Y, Moreno JR, Randall TD, Khader SA. Profiling early lung immune responses in the mouse model of tuberculosis. PLoS One. 2011;6(1):e16161.
24. Scanga C, Mohan V, Joseph H, Yu K, Chan J, Flynn J. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun. 1999;67(9):4531-4538.
25. Nouailles G, et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest. 2014;124(3):1268-1282.
26. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723-737.
27. Potian JA, Rafi W, Bhatt K, McBride A, Gause WC, Salgame P. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway. J Exp Med. 2011;208(9):1863-1874.
28. Erb KJ, Trujillo C, Fugate M, Moll H. Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Myco-bacterium bovis BCG from the lungs of mice. Clin Diagn Lab Immunol. 2002;9(3):727-730.
29. Rafi W, Bhatt K, Gause WC, Salgame P. "Primary memory immunity to Mycobacterium tuberculosis infection is not compromised in mice with chronic enteric helminth infection". Infect Immun. 2015;83(3):1217-1223.
30. Babu S, et al. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis. 2009;200(2):288-298.
31. Mattila JT, et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol. 2013;191(2):773-784.
32. Pessanha AP, Martins RA, Mattos-Guaraldi AL, Vianna A, Moreira LO. Arginase-1 expression in granulomas of tuberculosis patients. FEMS Immunol Med Microbiol. 2012;66(2):265-268.
33. Maarsingh H, Pera T, Meurs H. Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol. 2008;378(2):171-184.
34. Bisoffi Z, et al. Diagnostic accuracy of five sero-logic tests for Strongyloides stercoralis infection. PLoS Negl Trop Dis. 2014;8(1):e2640.
35. Mayer K, et al. The functional heterogeneity of type I effector T cells in response to infection is related to the potential for IFN-γ production. J Immunol. 2005;174(12):7732-7739.
36. Reiley WW, et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuber culosis infection are initiated in the medias-tinal lymph nodes. Proc Natl Acad Sci USA. 2008;105(31):10961-10966.
37. Zaretsky AG, Taylor JJ, King IL, Marshall FA, Mohrs M, Pearce EJ. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J Exp Med. 2009;206(5):991-999.
38. Crosby A, et al. Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. Am J Respir Crit Care Med. 2011;184(4):467-473.
39. + T cell responses after vaccination and during Myco-bacterium tuberculosis challenge. Nat Immunol. 2007;8(4):369-377.